152 related articles for article (PubMed ID: 32070732)
1. Fabrication and characterization of chitosan-based polymeric nanoparticles of Imatinib for colorectal cancer targeting application.
Bhattacharya S
Int J Biol Macromol; 2020 May; 151():104-115. PubMed ID: 32070732
[TBL] [Abstract][Full Text] [Related]
2. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
3. Oral delivery of imatinib through galactosylated polymeric nanoparticles to explore the contribution of a saccharide ligand to absorption.
Li Y; Yang B; Zhang X
Int J Pharm; 2019 Sep; 568():118508. PubMed ID: 31299337
[TBL] [Abstract][Full Text] [Related]
4. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.
Gupta M; Marwaha RK; Dureja H
Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications.
Udompornmongkol P; Chiang BH
J Biomater Appl; 2015 Nov; 30(5):537-46. PubMed ID: 26170212
[TBL] [Abstract][Full Text] [Related]
6. Folic acid-chitosan functionalized polymeric nanocarriers to treat colon cancer.
Bhaskaran NA; Jitta SR; Salwa ; Kumar L; Sharma P; Kulkarni OP; Hari G; Gourishetti K; Verma R; Birangal SR; Bhaskar KV
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127142. PubMed ID: 37797853
[TBL] [Abstract][Full Text] [Related]
7. Coated chitosan nanoparticles encapsulating caspase 3 activator for effective treatment of colorectral cancer.
Jain A; Jain S; Jain R; Kohli DV
Drug Deliv Transl Res; 2015 Dec; 5(6):596-610. PubMed ID: 26334865
[TBL] [Abstract][Full Text] [Related]
8. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
[TBL] [Abstract][Full Text] [Related]
9. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Chaubey P; Patel RR; Mishra B
Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
[TBL] [Abstract][Full Text] [Related]
10. Rifaximin - Chitosan Nanoparticles for Inflammatory Bowel Disease (IBD).
Kumar J; Newton AMJ
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(1):41-52. PubMed ID: 28034350
[TBL] [Abstract][Full Text] [Related]
11. In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia.
Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; Kaya Z; Ozel AE; Akyuz S
Curr Comput Aided Drug Des; 2020; 16(2):104-121. PubMed ID: 31244443
[TBL] [Abstract][Full Text] [Related]
12. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132.
Mehrotra A; Nagarwal RC; Pandit JK
Chem Pharm Bull (Tokyo); 2011; 59(3):315-20. PubMed ID: 21372411
[TBL] [Abstract][Full Text] [Related]
13. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
14. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.
Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H
Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160
[TBL] [Abstract][Full Text] [Related]
15. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.
Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312
[TBL] [Abstract][Full Text] [Related]
16. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
Shahbazi MA; Hamidi M; Mohammadi-Samani S
J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
[TBL] [Abstract][Full Text] [Related]
17. Interfacial Phenomenon Based Biocompatible Alginate-Chitosan Nanoparticles Containing Isoniazid and Pyrazinamide.
Kushwaha K; Dwivedi H
Pharm Nanotechnol; 2018; 6(3):209-217. PubMed ID: 29938624
[TBL] [Abstract][Full Text] [Related]
18. Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats.
Shailender J; Ravi PR; Reddy Sirukuri M; Dalvi A; Keerthi Priya O
Drug Dev Ind Pharm; 2018 Jul; 44(7):1109-1119. PubMed ID: 29409342
[TBL] [Abstract][Full Text] [Related]
19. Intranasal Drug Delivery of Frovatriptan Succinate-Loaded Polymeric Nanoparticles for Brain Targeting.
Deepika D; Dewangan HK; Maurya L; Singh S
J Pharm Sci; 2019 Feb; 108(2):851-859. PubMed ID: 30053555
[TBL] [Abstract][Full Text] [Related]
20. Formulation and Characterization of Rutin Loaded Chitosan-alginate Nanoparticles: Antidiabetic and Cytotoxicity Studies.
Surendran V; Palei NN
Curr Drug Deliv; 2022; 19(3):379-394. PubMed ID: 34636298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
